Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old

Hypertension Research

Volumn 39, Issue 4, 2016, Pages 245-253

  Liu, Zhendong ^a   Zhao, Yingxin ^a   Zhang, Hua ^a   Chai, Qiang ^a   Cui, Yi ^b   Diao, Yutao ^a   Xiu, Jianchao ^a   Sun, Xiaolin ^a   Jiang, Guosheng ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

blood pressure variability; cognitive function; oldest old; self measured blood pressure at home; white matter lesions

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE VARIABILITY; CHINA; COEFFICIENT OF VARIATION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SELF MONITORING; STATISTICAL PARAMETERS; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; WHITE MATTER LESION; BLOOD PRESSURE; BRAIN; DIAGNOSTIC IMAGING; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WHITE MATTER;

AGED, 80 AND OVER; BLOOD PRESSURE; BRAIN; COGNITION DISORDERS; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; WHITE MATTER;

EID: 84962630521     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.135     Document Type: Article

References (44)

1. Peters R, Bekett N, Geneva M, Tzekova M, Lu FH, Poulter R, Gainsborough N, Williams B, De Vernejoul MC, Fletcher A, Bulpitt C. Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET. Age Ageing 2009; 38: 521-527
2. Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, Liu Z, Zhang W. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow up study. J AmMed Dir Assoc 2014; 15: 904-910
3. Mok V, Wong KK, Xiong Y, Wong A, Schmidt R, Chu W, Hu X, Leung EY, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong ST. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion. J Neurol Neurosurg Psychiatry 2011; 82: 52-57
4. Peters R, Beckett N, Forette F, Tuomilehto J, Ritchie C, Walton I, Waldman A, Clarke R, Poulter R, Fletcher A, Bulpitt C. Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): A crosssectional analysis. Int Psychogeriatr 2009; 21: 359-365
5. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S4-S9
6. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Medical Research Council Cognitive Function and Ageing Study. Age, neuropathology, and dementia. N Engl J Med 2009; 360: 2302-2309
7. Poon LW, Woodard JL, Stephen Miller L, Green R, Gearing M, Davey A, Arnold J, Martin P, Siegler IC, Nahapetyan L, Kim YS, Markesbery W. Understanding dementia prevalence among centenarians. J Gerontol A Biol Sci Med Sci 2012; 67: 358-365
8. Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, Van Der Flier WM, Van Berckel BN, Scheltens P, Visser PJ, Amyloid PET Study Group, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, Van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Jan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ. Prevalence of amyloid PET positivity dementia syndromes: A meta-Analysis. JAMA 2015; 313: 1939-1949
9. Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, Van Berckel BN, Bibeau K, Blennow K, Brooks DJ, Van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, Van Der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, De Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, De Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergard HM, Morris JC, Mroczko B, Van Der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende De Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, Van Waalwijk Van Doorn LJ, Waldemar G, Wallin A, Wallin AK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-Analysis. JAMA 2015; 313: 1924-1938
10. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-Analysis. BMJ 2010; 341: c3666
11. Gunning-Dixon FM, Brickman AM, Cheng JC, Alexopoulos GS. Aging of cerebral white matter: A review of MRI findings. Int J Geriatr Psychiatry 2009; 24: 109-117
12. Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012; 79: 741-747
13. Teipel SJ, Grothe M, Lista S, Toschi N, Garaci FG, Hampel H. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer Disease. Med Clin N Am 2013; 97: 399-424
14. Frings L, Yew B, Flanagan E, Lam BYK, Hüll M, Huppertz HJ, Hodges JR, Hornberger M. Longitudinal grey and white matter changes in frontotemporal dementia and Alzheimer?s disease. PLoS ONE 2014; 9: e90814
15. Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, DeCarli C, Fox NC. Alzheimer?s Disease Neuroimaging Initiative. Vascular and Alzheimer?s disease markers independently predict brain atrophy rate in Alzheimer?s disease neuroimaging initiative controls. Neurobiol Aging 2013; 34: 1996-2002
16. Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer?s disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 2009; 11: 181-190
17. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222
18. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry 2000; 15: 803-812
19. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkov R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, Van De Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, Van De Borne P, Vlachopoulos C, Volpe M, Wood DA. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for themanagement of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
20. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, Van Zwieten P, Waeber B, Williams B. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187
21. O?Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848
22. Hashimoto T, Kikuya M, Ohkubo T, Satoh M, Metoki H, Inoue R, Asayama K, Kanno A, Obara T, Hirose T, Hara A, Hoshi H, Totsune K, Satoh H, Sato H, Imai Y. Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men: the Ohasama Study. Am J Hypertens 2012; 25: 883-891
23. Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: A systematic review. Hypertens Res 2014; 37: 565-572
24. Asayama K, Wei FF, Liu YP, Hara A, Gu YM, Schutte R, Li Y, Thijs L, Staessen JA. Does blood pressure variability contribute to risk stratification? Methodological issues and a review of outcome studies based on home blood pressure. Hypertens Res 2015; 38: 97-101
25. Liu Z, Wei F, Zhao Y, Lu F, Zhang H, Diao Y, Song H, Qi Z. Day-by-day variability of selfmeasured blood pressure at home associated with cold pressor test norepinephrine, and heart rate variability in normotensive to moderate hypertensive. Int J Cardiol 2013; 15: 4574-4576
26. Liu Z, Zhao Y, Lu F, Zhang H, Diao Y. Day-by-day variability in self-measured blood pressure at home: effects on carotid artery atherosclerosis, brachial flow-mediated dilation, and endothelin-1 in normotensive and mild-moderate hypertensive individuals. Blood Press Monit 2013; 18: 316-325
27. Stergiou GS, Giovas PP, Gkinos CP, Patouras JD. Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol. Blood Press Monit 2007; 12: 185-188
28. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, Van Der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355
29. Godin O, Tzourio C, Mailard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123: 266-273
30. White WB, Wolfson L, Wakefield DB, Hall CB, Campbell P, Moscufl N, Schmidt J, Kaplan RF, Pearlson G, Guttmann CR. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011; 124: 2312-2319
31. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. Fsl. NeuroImage 2012; 62: 782-790
32. Olindo S, Cabre P, Deschamps R, Chatot-Henry C, Rene-Corail P, Fournerie P, Saint-Vil M, May F, Smadja D. Acute stroke in the very elderly: epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke 2003; 34: 1593-1597
33. Nishinaga M, Takata J, Okumiya K, Matsubayashi K, Ozawa T, Doi Y. High morning home blood pressure is associated with a loss of functional independence in the community-dwelling elderly aged 75 years or older. Hypertens Res 2005; 28: 657-663
34. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, Gu YM, Kuznetsova T, Jacobs L, Staessen JA. Within-subject blood pressure level-not variability-predicts fatal and nonfatal outcomes in a general population. Hypertension 2012; 60: 1138-1147
35. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ. Variability in midlife systolic blood pressure is related to late-life brain white matter lesions: the Honolulu-Asia Aging study. Stroke 2002; 33: 26-30
36. Matsumoto A, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, Hashimoto T, Hara A, Hirose T, Obara T, Metoki H, Asayama K, Hosokawa A, Totsune K, Hoshi H, Hosokawa T, Sato H, Imai Y. Day-To-day variability in home blood pressure is associated with cognitive decline: the Ohasama study. Hypertension 2014; 63: 1333-1338
37. Okada H, Fukui M, Tanaka M, Matsumoto S, Mineoka Y, Nakanishi N, Tomiyasu K, Nakano K, Hasegawa G, Nakamura N. Visit-To-visit variability in systolic blood pressure is a novel risk factor for the progression of coronary artery calcification. Hypertens Res 2013; 36: 996-999
38. Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K. Impact of visit-To-visit variability of blood pressure on deterioration of renal function in patients with nondiabetic chronic kidney disease. Hypertens Res 2013; 36: 151-157
39. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characterisitics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701
40. Barnes J, Bartlett JW, Van De Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. A meta-Analysis of hippocampal atrophy rates in Alzheimer?s disease. Neurobiol Aging 2009; 30: 1711-1723
41. Maule S, Caserta M, Bertello C, Verhovez A, Naso D, Bisbocci D, Veglio F. Cognitive decline and low blood pressure: the other side of the coin. Clin Exp Hypertens 2008; 30: 711-719
42. Cecchi E, Giglioli C, Valente S, Lazzeri C, Gensini GF, Abbate R, Mannini L. Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis 2011; 214: 249-256
43. Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Park KU, Kim CH. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J 2008; 72: 293-298
44. Li R, Cui J, Shen Y. Brain sex matters: estrogen in cognition and Alzheimer?s disease. Mol Cell Endocrinol 2014; 389: 13-21